Recently Reported Dual-Drug Co-Delivery of Liposomal-Based Chemotherapeutics to Treat Breast Cancer

David R Khan, Alexandra E Muniz, Jason C Yarbrough and Crystal N Moss
Additional contact information
Jason C Yarbrough: Department of Chemistry and Physics, West Texas A&M University, Canyon, TX 79016, USA
Crystal N Moss: Department of Biological and Physical Sciences, Amarillo College, Amarillo, TX 79109, USA

Biomedical Journal of Scientific & Technical Research, 2021, vol. 39, issue 2, 31197-31199

Abstract: The use of nanocarriers such as liposomes to co-encapsulate more than one anticancer drug has been shown to be a promising strategy in cancer treatment with respect to overcoming multidrug resistance (MDR)...

Keywords: Breast Cancer; Retention; Nanocarriers; Chemosensitizer; Liposomes; Dual-Drug; Liposomes; Co-Delivery; Hyperthermia; Chemotherapeutics (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.006280.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.006280.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:39:y:2021:i:2:p:31197-31199

DOI: 10.26717/BJSTR.2021.39.006280

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().